TY  - JOUR 
AU  - Antolín Novoa, Silvia
AU  - Acea Nebril, Benigno
AU  - Albaina Latorre, Luis
AU  - Concha Lopez, Angel
AU  - Santiago Freijanes, Mª Paz
AU  - García-Caballero Parada, Tomas
AU  - Mosquera Oses, Joaquín José
AU  - Varela Romero, José Ramón
AU  - Soler Fernandez, Rafaela
AU  - Calvo Martínez, Lourdes
PY  - 2019
SN  - 1179-1314
UR  - http://hdl.handle.net/20.500.11940/15371
AB  - Objective: The aim of this study was to evaluate the efficacy, cardiotoxicity profile and long-term benefits of neoadjuvant therapy in human epidermal growth factor receptor 2-positive operable breast cancer patients. Patients and methods: A total of...
LA  - eng
TI  - Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
DO  - 10.2147/BCTT.S179750
T2  - BREAST CANCER (DOVE MEDICAL PRESS)
M2  - 29
KW  - CHUAC
KW  - CHUS
VL  - 11
ER  -